Legal & General Group PLC Boston Scientific Corp Transaction History

Legal & General Group PLC

$420 Billion
Q1 2024

A detailed history of Legal & General Group PLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Legal & General Group PLC holds 13,439,358 shares of BSX stock, worth $1.02 Billion. This represents 0.22% of its overall portfolio holdings.

Number of Shares

13,439,358

Previous 13,524,199 0.63%

Holding current value

$1.02 Billion

Previous $782 Million 17.73%

% of portfolio

0.22%

Previous 0.2%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$57.6 - $68.62 $4.89 Million - $5.82 Million	-84,841 Reduced 0.63%	13,439,358 $920 Million
Q4 2023 Feb 15, 2024	BUY	$48.64 - $57.81 $110 Million - $131 Million	2,270,831 Added 20.18%	13,524,199 $782 Million
Q3 2023 Nov 14, 2023	SELL	$50.19 - $54.68 $12.6 Million - $13.8 Million	-251,576 Reduced 2.19%	11,253,368 $594 Million
Q2 2023 Aug 14, 2023	BUY	$49.72 - $54.64 $36.9 Million - $40.6 Million	742,518 Added 6.9%	11,504,944 $622 Million
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $10.7 Million - $11.8 Million	236,481 Added 2.25%	10,762,426 $538 Million

Q4 2022 Feb 14, 2023	SELL	$39.56 - $47.22 $12.6 Million - $15.1 Million	-319,607 Reduced 2.95%	10,525,945 $487 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $11.8 Million - $35.2 Million	-320,625 Reduced 2.87%	10,845,552 $420 Million
Q2 2022 Aug 22, 2022	BUY	$35.24 - $47.1 $14.4 Million - $19.3 Million	409,391 Added 3.81%	11,166,177 $416 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $36 Million - $39.7 Million	880,914 Added 8.92%	10,756,786 $476 Million
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $15.2 Million - $17.9 Million	-398,544 Reduced 3.88%	9,875,872 $420 Million
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $22.7 Million - $25.3 Million	551,217 Added 5.67%	10,274,416 $446 Million
Q2 2021 Aug 12, 2021	BUY	$38.58 - $44.24 $20.9 Million - $23.9 Million	541,219 Added 5.89%	9,723,199 $416 Million
Q1 2021 May 17, 2021	SELL	$35.27 - $39.67 $3.89 Million - $4.38 Million	-110,300 Reduced 1.19%	9,181,980 $355 Million
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $7.88 Million - $9.97 Million	237,625 Added 2.62%	9,292,280 $334 Million
Q3 2020 Nov 13, 2020	SELL	$34.44 - $42.23 $612,515 - $751,060	-17,785 Reduced 0.2%	9,054,655 $346 Million
Q2 2020 Aug 14, 2020	SELL	$30.19 - $39.11 $2.91 Million - $3.78 Million	-96,545 Reduced 1.05%	9,072,440 $319 Million
Q1 2020 May 14, 2020	BUY	$25.83 - $45.71 $10 Million - $17.7 Million	387,556 Added 4.41%	9,168,985 $300 Million
Q4 2019 Feb 13, 2020	BUY	$37.87 - $45.37 $8.58 Million - $10.3 Million	226,587 Added 2.65%	8,781,429 $397 Million
Q3 2019 Nov 13, 2019	SELL	$40.31 - $43.45 $1.35 Million - $1.45 Million	-33,425 Reduced 0.39%	8,554,842 $348 Million
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $628,345 - $773,597	17,999 Added 0.21%	8,588,267 $369 Million
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $51.6 Million - $63.9 Million	1,567,394 Added 22.38%	8,570,268 $329 Million
Q4 2018 Feb 15, 2019	BUY	$31.73 - $39.04 $19 Million - $23.4 Million	598,647 Added 9.35%	7,002,874 $247 Million
Q3 2018 Nov 20, 2018	BUY	$32.83 - $38.63 $9.21 Million - $10.8 Million	280,645 Added 4.58%	6,404,227 $247 Million
Q2 2018 Aug 10, 2018	SELL	$26.84 - $34.32 $7 Million - $8.95 Million	-260,671 Reduced 4.08%	6,123,582 $200 Million
Q1 2018 May 17, 2018	SELL	$25.2 - $28.54 $7.42 Million - $8.4 Million	-294,307 Reduced 4.41%	6,384,253 $174 Million
Q4 2017 Feb 13, 2018	BUY	$24.79 - $29.8 $166 Million - $199 Million	6,678,560	6,678,560 $166 Million

Others Institutions Holding BSX

# of Institutions

1,319

Shares Held

1.17B

Call Options Held

5.92M

Put Options Held

5.75M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $108B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Boston Scientific Corp Transaction History